The exome of SC_9008 included an AR mutation, T878A that broadens ligand specificity, an inactivating TP53 mutation, and a recurrent mutation in SPOP. A frameshifting indel disrupting MSH2 was identified which likely contributed to the hyper-mutated genome of this tumor. Here, AR is linked to neoplasm.